Huimin Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huimin Liu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chun-Zhi Jin
Cell Factory Research Centre, Korea Research Institute of Bioscience & Biotechnology (KRIBB), Daejeon 34141, Republic of Korea
1 shared publication - Kee-Sun Shin
Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea
1 shared publication - Le Kang
Key Laboratory of Nanchong City of Ecological Environment Protection and Pollution Prevention in Jialing River Basin, College of Environmental Science and Engineering, China West Normal University, Nanchong 637002, China
1 shared publication - Long Jin
Co-Innovation Center for Sustainable Forestry in Southern China, College of Ecology and Environment, Nanjing Forestry University, Nanjing, China
1 shared publication - Ting Li
Key Laboratory of Nanchong City of Ecological Environment Protection and Pollution Prevention in Jialing River Basin, College of Environmental Science and Engineering, China West Normal University, Nanchong 637002, China
1 shared publication - Ye Zhuo
Cell Factory Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea
1 shared publication
Latest Publications
- Open Access
Bioconversion of Geniposide from Gardenia jasminoides via Levilactobacillus Enhancing Anti-Inflammatory Activity
Genipin, one of Gardenia jasminoides’ bioactive components, exhibits superior therapeutic efficacy compared to geniposide, though it is present in much lower concentrations. Conventional hydrolysis methods using acids or organic solvents can enhance genipin yield but often raise environmental and safety concerns. This study aimed to increase genipin production through whole-cell bioconversion of geniposide to genipin using lactic acid bacteria (LABs). A total of 191 LAB strains were isolated from kimchi. Levilactobacillus sp. LN180102 showed the highest bioconversion activity, which was up to 40%. Docking analysis and esculin assay confirmed the beta-glucosidase activity. The anti-inflammatory effects of the fermented extract were enhanced by 28.5% in RAW 264.7 cells in vitro. Additionally, Levilactobacillus sp. LN180102 is probiotic-friendly and exhibits a high tolerance for phenol, bile, and acid. In their entirety, these discoveries have the potential to illuminate the ways in which Gardenia jasminoides can be functionally improved through whole-cell bioconversion, thereby enabling individuals to lead healthier lifestyles.
Open AccessBioconversion of Geniposide from Gardenia jasminoides via Levilactobacillus Enhancing Anti-Inflammatory Activity
Genipin, one of Gardenia jasminoides’ bioactive components, exhibits superior therapeutic efficacy compared to geniposide, though it is present in much lower concentrations. Conventional hydrolysis methods using acids or organic solvents can enhance genipin yield but often raise environmental and safety concerns. This study aimed to increase genipin production through whole-cell bioconversion of geniposide to genipin using lactic acid bacteria (LABs). A total of 191 LAB strains were isolated from kimchi. Levilactobacillus sp. LN180102 showed the highest bioconversion activity, which was up to 40%. Docking analysis and esculin assay confirmed the beta-glucosidase activity. The anti-inflammatory effects of the fermented extract were enhanced by 28.5% in RAW 264.7 cells in vitro. Additionally, Levilactobacillus sp. LN180102 is probiotic-friendly and exhibits a high tolerance for phenol, bile, and acid. In their entirety, these discoveries have the potential to illuminate the ways in which Gardenia jasminoides can be functionally improved through whole-cell bioconversion, thereby enabling individuals to lead healthier lifestyles.